IL6 and myasthenia gravis: Primarily, the predominant cytokine milieu in MG - particularly interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) (77) - can directly upregulate TLRs’ expression (78), creating a self-perpetuating cycle of inflammation.